sspalmo
19 minutes ago
You piqued my curiosity with this statement "FWIW, Merganthaler has failed against ENZC and its officers at least twice, maybe 3 times now. JMHO.", so I went back and took a quick review. These are the only two cases that I see with the name Mergenthaler. There are other cases that I see with the surname "Truong" which is the other plaintiff in this case, but they are not Mac Truong and do not seem to be about Enzolytics or any of if its previous iterations.
https://www.courtlistener.com/docket/67681385/mergenthaler-v-zimbler/
https://www.courtlistener.com/docket/67807413/mergenthaler-v-zimbler/
The first case was not ruled on and transferred to a different court, and I would not consider it a failure because it turned into the second case (the one I am referring to). The second case (which is the one I am referring to) is still ongoing.
If Zimbler "purchased" an OTC ticker from someone and only paid the 10% down payment and failed to pay the remaining 90% owed, then did he really own it? Without doing a deep dive, this is what I recall the Mergenthaler case being about.
I apologize to everyone here, I earlier mistyped the name Mergenthaler as Merganthaler. To anybody that wants to research this it is Mergenthaler.
I am not claiming that Peter Mergenthaler has a valid case. That is for the courts to decide. If there are more cases that involve Mergenthaler that I am not aware of please list them.
sspalmo
5 hours ago
I meant that the Merganthaler case seemed to have more potential than the Kona and Cimarron cases. If I remember correctly, the Merganthaler case was about whether or not Zimbler actually completed the purchase of Enzolytics (or whatever it was called at the time of the sale). I only have access to courtlistener to see the filings, so I am unaware of who has been dismissed as a defendant. I have not spent a lot of time looking into the Merganthaler case. The Kona and Cimarron cases appeared to be attempts at a money grab. If I recall correctly one of them was suing for $450 million dollars. I wonder where they came up with that figure.
In my opinion, the main case to watch is GLD v SAGA. Those of us who have been following Enzolytics (yourself included) have seen what happened with the alleged SPAC deal. This goes far beyond the "fraudulent four". Barry and Kelli didn't push this through on their own.
Charles was CEO at the time this deal was pushed through, not Harry. Chandra and Joseph were also still a part of Enzolytics while this happened. Who knew what, and when did they know it. Who at Enzolytics received the 45 million shares with voting rights? If the CCC team wasn't complicit in what happened with the SAGA transaction, why didn't they come out sooner and let the investors they supposedly care for know that something is wrong? The CCC team wasn't removed until March 25th 2024, well after this deal was allegedly completed. There are a lot of unanswered questions at this time.
The Company has received numerous inquiries from various entities and individuals regarding the status of the SAGA transaction and the status of the operations of VIRO and BGEN. With the completed sale of the operating subsidiaries the Company will no longer be the source of news on the progress and developments of VIRO or BGEN. SAGA is a NASDAQ entity and takes a more conservative approach to press releases as they are a SEC reporting entity and SAGA's policy is to report material events in 8-K filings accompanied by a press release.
As a party to the business combination agreement with SAGA the Company can report that the transaction is complete. Prior to SAGA receiving any notice of what the Company believes is a frivolous action, designed and implemented to do nothing but cause harm to ENZC and the SAGA Shareholders, ENZC had voted its shares received as payment from the sale of the operating subsidiaries, VIRO and BGEN. These shares represent a quorum and more than enough votes to ensure passage of the two proposals, rendering the shareholder vote a fait accompli.
Charles Cotropia, CEO of Enzolytics, said: "Our focus is on our technologies for developing successful therapeutics for treating many infectious diseases. We have full confidence in each therapeutic being developed. We also have full confidence in advancing them under the Business Combination with Sagaliam Acquisition Corp. Our business combination with Sagaliam will ensure the necessary funding for the substantial advancement we know can be achieved. Efforts to thwart those plans are without merit and will be fully addressed as we proceed and in the right forums. While fully addressing these business matters diverts some attention from our main technological goals, it will clearly not prevent our success."
https://www.otcmarkets.com/stock/ENZC/news/Enzolytics-Inc-Files-Amended-December-31-2022-OTC-Report-with-Audited-Financials-and-Unaudited-September-30-2023-Quarter?id=422061
Valuator2
7 hours ago
I agree on GLD v SAGA, but why do you think the Merganthaler v Zimbler case has "more potential"? IMO, it doesn't look like they are having much success against any of the defendants, most of whom (if not all) were apparently dismissed from the case on May 14, 2024. The latest filing by the plaintiffs is an appeal of those dismissals, of course, with no ruling yet. So, who knows what could happen with this one.
I will say though, that if you look at the history of the co-plaintiff's filings in NY courts for Mrs. Mergenthaler, especially the various judges' comments, you'll find some interesting information and a pattern of persistence to keep filing lawsuits despite losses and reprimands for doing so...JMHO. FWIW, Merganthaler has failed against ENZC and its officers at least twice, maybe 3 times now. JMHO.
docsetc
9 hours ago
Harry must have not taken ITV-1 back into ENZC, after the SAGA deal fell through and legally, SAGA no longer owned ENZC or its IP's, meaning Harry sold it off for a bargain-basement price to Kostiner, or dummy Savoy would not be suing SAGA. The trust most assuredly, but not SAGA.
Just nonsense. Another lawsuit over ITV-1, that does not work and failed toxicology tests, so its bitching over the funds Harry locked away in the trust some time back. His Bulgarian Mafia partners know of it, hence the ambulance chasing lawsuit.
Nothing currently left in ENZC, less than that in Sagaliam, just do-do's looking to not go extinct.
GLTa
docsetc
9 hours ago
Maybe not, this is an HIV preventative treatment, that was trial tested to work under certain conditions, not a curing treatment, or even a treatment to beat the virus back, but only to act as a shield against getting it in the first place, under certain conditions. This could piss away into a drain tomorrow.
docsetc
1 day ago
Okay, one reminder. This was posted by Chandra on 'X' on 6/6/2024, and it coordinates with what he called me about, and his calls to others on other boards, and it relates to a couple of his more recent posts during his travels of this last week.
It would be more assuring, if Charles also put up a public post claiming the same, that something is afoot for current ENZC shareholders.
GLTA
docsetc
1 day ago
I sure hope so, but I worry a bit that more focus is coming in on 'maybe pandemics' so close to an election from media sources who love to back Leftist Tyrants.
I'm more concerned with getting some overdue information from CCC. It's not illegal to let their past investors in another company have some idea of how and when to prepare for whatever is about to happen. They don't have to announce it as a public company.
They called me, KoP, Godfather Capital and someone over in Discord that we know about, so getting the word out is not an alien concept to them. The other guys began posting the same stuff I told folks here. I wish Chandra would get back to substance over new company fluff. Maybe CCC could use an old Army slogan of "no one gets left behind", especially who were on their team.
That's what I would do, but we'll see.
docsetc
2 days ago
Me too. I have some experience dealing with Nigerian Scammers, In a past life, a company I worked for as inside sales director, we sold some product into Nigeria for oilfield laborers. I entered my company name and my roadie email address at the Chamber of Commerce in Lagos. Yes, they have one.
Ever since, my junk mail folder to that email account, which I still use, is jam-packed with scammer's emails every morning. One of those scammers, we traced his server's IP address, and the corrupt Nigerian Lagos PD actually shut him down. Then I began receiving threats against my life on both phone and emails, telling me I was not safe, even in my own US home.
F-them. I changed cell numbers since then, so all I get now are emails. They share them with other scammers. A lot of radicals are there, more than equal to ripping up a few Bulgarians, you are right.
GLTA
docsetc
2 days ago
Yeah, sure are a lot of legal cases involving cash payments, loans and shares for a company that allegedly-according-to-the-bashers, never had anything and is/was all fake. SAGA sure was, everyone could see that, but SAGA and all of these others wanted ENZC, and now with Zhabilov and Sharabura making that an empty-shell joke of an 'operation', all these clowns still in the courts will be skipping out soon.
GLTY
docsetc
2 days ago
Hey TJ, thanks for this, interesting reading.
I forwarded this onto my brother, a contacts and trust lawyer. He doesn't handle class-actions, so don't ask.
He pointed out, since the expressed work of Bioclinetics is/was the same as MABS-Tech and a lot of the same at Andexus, if you wanted, you'd have a solid claim to have your proffers paid in full, once a value was calculated for whatever success level either company achieves with the Clone3/7 products, you may be due proper remittance from Charles Cotropia.
He just pointed out as I began typing this, that probably only applies to Clone3 success markers, as Clone7 was developed after this offer(?) Also, more to the point, because the Bioclientics work / IP was merged into ENZC and left ENZC with Cotropia when the split occurred in late March of 2024, you and anyone else holding these notes could be due make-hole remedies if and when sales of Clone3 products are seen as profitable on the books.
Special note, that until commercial sales and licensing engage with customers and/or partners, the company can be defined as not profitable, but still in a research stage. So even if the stock price soars, there may be a waiting period before you get your shares/payment.
I'd send a notice of inquiry directly to Charles Cotropia, if you haven't already, with copies of receipts, canceled checks, signed docs etc, and let him know once Clone3 success is obvious, regardless of which company the IP runs out of, that your due your shares, period. At the very least, he'd have to go back and review legal linkage in liability for issuing this kind of agreement structure to you and to others. Bioclinetics was merged with ENZC, and ENZC under Zhabilov tried to sell off those IP's at one point. Now that Charles has them back clean and tight, he still bears some responsibility for contractual agreements he made here.
He may try to invoke some form of corporate defense, but the way he left ENZC, where he merged the companies, voluntarily in legal terms, he should be still on the hook here.
Personally, I'd open a dialogue directly with him on this, showing your good faith, but also showing determination and a chance of legal risk if they don't come up with satisfying the promise made to you. If you still have the receipts, in this case your payments, their agreement, anything you signed off on, you probably have a case.
My brother would love to see the funding agreement you had to sign for the donation into these sites; he's curious what, for an OTC:PINK launch, they read like.
GLTA (Did you also invest in ENZC shares separately?)
MrMyers
2 days ago
@docsetc -- Have you researched NIKA Pharmaceuticals lately? I'd love to hear your thoughts on this company with HIV treatments and facilities in Bulgaria that sound vaguely familiar. The following is a recent press release regarding HIV treatment:
HENDERSON, Nev., July 18, 2024 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) announces the signing of a distribution agreement for the Republic of Nigeria.
The extensive negotiations with I.Conntact-Connect Limited finalized on June 11, 2024 and will allow NIKA to have a strong partner in a key market of 229 million people where recent estimates report a 2.1% national HIV prevalence (approximately 2 million people)1. Under the agreement’s terms, NIKA will receive €1,980 per each set of ITV-1 with two sets necessary for each treatment, which could result in €7.9 billion revenue. More importantly, it will help the battle against a national HIV epidemic, in which 190,950 HIV/AIDS infections are registered each year, with 41,000 cases among children, most of whom do not have access to other therapies.2
NIKA’s CEO Dimitar Savov stated: “Since Nigeria is important for NIKA, in addition to the distribution agreement, we are preparing to open a satellite office there that will serve as a hub for the entire West Africa region.”
docsetc
2 days ago
Ah, you're just not worth the effort
Just for fun, let's review your lies:
-- I never said my daughter worked in my company, she works in the Texas A&M system for Biological Research, and was a big help in getting me a guided tour of their College Station research facility and the ENZC abandoned labs back in early April. My small company's annual revenue tops $2 mill per year, and growing. I built that out of nothing, so lose the grip on that member in your closet. I have the videos and photos, proved it easily.
-- No one who held onto their shares did so 'selfishly' most were so far underwater so quickly, selling off was no real advantage.
-- Dr. Chandra did call me, might call again, so peddle your sh!t elsewhere. I have his number on my cell phone now, and thought about actually putting that here, but I won't risk numb-nuts like you, still accumulating on the cheap and lying about it. Harrassing him and burning any trust he placed in me on the call. is not to anyone's advantage here.
-- Love bashers like you trying to chum-up some manliness online, and never can, so pathetic. Hey, you know, HALB needs another gurly-man to bash their hopeless boat, try over there.
-- Funny how you and Trading G always show up when someone mentions holding shares and buying a little more.
-- Remember not to neglect your Cannibis stocks now....
-- I was straight up with Chandra, citing how my criticism was constructive, and my support wavering due to the stock's performance. You know, honest stuff.
-- Wait, you don't know about honest stuff!
ROTFLMAO at your gurly attempts to sound tough here kid.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Timing101
4 hours ago
I-Glow
20 hours ago
Dspetry
1 day ago
1hunglo
2 days ago
Hot Features
Premium
